EFFECTS OF CHROMIUM PICOLINATE ON OXIDATIVE STRESS AND HYPERGLYCEMIA IN EXPERIMENTAL TYPE 2 DIABETIC RATS
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i10.28608Keywords:
Type 2 diabetes, Hyperglycemia, Oxidative stress, Chromium picolinateAbstract
Objective: In this study, we aimed to determine the effects of chromium picolinate (CrPic) on diabetes, one of the most common and fatal diseases in the world, and its associated oxidative damages.
Methods: CrPic (100 μg/kg) and metformin (1000 mg/kg) were orally administered for 21 days in rats with nicotinamide + streptozotocin-induced Type 2 diabetes.
Results: Significant decreases in fasting blood glucose levels were observed 14 days after initial administration in both CrPic (p<0.01) and metformin (p<0.001) groups compared with a diabetic control group (DC). Malondialdehyde (MDA) levels of all tissues were significantly higher in the DC group than in a normoglycemic control group (p<0.001). MDA levels of the CrPic group significantly decreased in heart (p<0.05) and liver (p<0.01) tissues. Glutathione (GSH) and catalase (CAT) levels in heart, kidney, and liver tissues increased in CrPic group (GSH p<0.001, p<0.05, and p<0.01; CAT p<0.001, p<0.001, and p<0.05, respectively). Superoxide dismutase enzyme levels significantly increased in CrPic group in the liver tissue (p>0.001), but no such changes were observed in heart and kidney tissues (p>0.05).
Conclusion: The results obtained from this study indicate that CrPic may be effective in alleviating hyperglycemia and its consequent oxidative damage in experimental Type 2 diabetes.
Downloads
References
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:5-10.
Kalsi A, Singh S, Taneja N, Kukal S, Mani S. Current treatments for Type 2 diabetes, their side effects and possible complementary treatments. Int J Pharm Pharm Sci 2015;7:13-8.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35:64-1.
Paneni F, Beckman JA, Creager A, Cosentino F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. EHJ 2013;34:2436-43.
Shaikh H, Shrivastava VK. Effects of streptozotocin induced diabetes mellitus Type 1 on the rat brain antioxidant status and activity of acetyl-cholinesterase: A novel and potential treatment by vitex negundo. Int J Pharm Pharm Sci 2014;6:252-6.
Banerjee A, Maji B, Mukherjee S, Chaudhuri K, Seal T. In vitro anti-diabetic and anti-oxidant activities of ethanol extract of tinospora sinensis. Int J Curr Pharm Res 2017;9:42-7.
International Diabetes Federation: Diabetes Complications Congress, Hyderabad, India 25-27 October 2018. Available from: https://www.idf. org/our-activities/congress/hyderabad-2018.html.
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813.
Vinotha AT, Palanimuthu P. Effect of enalapril and metformin on oxidative stress in newly diagnosed Type 2 diabetes mellitus and hypertensive patients. Asian J Pharm Clin Res 2016;9:69-2.
Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: The oxidative stress. Nutr Metab Cardiovasc Dis 2010;20:72-7.
Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Squ Med 2012;12:5-18.
Rains JL, Jain SK. Oxidative stress, insülin signaling, and diabetes. Free Radic Biol Med 2011;50:567-5.
Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2003;17:24-38.
Jain SK, Kannan K. Chromium chloride inhibits oxidative stress and TNF-alpha secretion caused by exposure to high glucose in cultured U937 monocytes. Biochem Biophys Res Commun 2001;289:687-1.
Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care 2004;27:2741-51.
Lewicki S, Zdanowski R, Kryżowska M, Lewicka A, Dębski B, Niemcewicz M, et al. The role of chromium III in the organism and its possible use in diabetes and obesity treatment. Ann Agric Environ Med 2014;21:331-5.
Striffler JS, Polansky MM, Anderson RA. Dietary chromium decrease sinsülin resistance in rats fed a high-fat, mineral-imbalanced diet. Metabolism 1998;47:396.
Abdourahman A, Edwards JG. Chromium supplementation improves glucose tolerance in diabetic goto-kakizaki rats. IUBMB Life 2008;60:541-8.
Nancy AL, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 1994;17:1449-52.
Rajendran K, Manikandan S, Nair LD, Karuthodiyil R, Vijayarajan N, Gnanasekar R, et al. Serum chromium levels in Type 2 diabetic patients and its association with glycaemic control. J Clin Diagn Res 2015;9:OC05-8.
Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willett WC, et al. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 2004;27:2211-6.
Hasan HG, Ismael PA, Aziz, NM. Evaluation of serum chromium levels in patients with Type 1 and 2 diabetes mellitus and insülin resistance. Int J Basic Appl Sci 2012;12:69-3.
Shirwaikar A, Rajendran K, Kumar CD, Bodla R. Antidiabetic activity of aqueous leaf extract of Annonasquamosa in streptozotocin– nicotinamide Type 2 diabetic rats. J Ethnopharmacol 2004;91:171-5.
Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malonyldialdehyde) in biochemical systems. Anal Biochem 1966;16:359-4.
Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with ellman’s reagent. Anal Biochem 1968;25:192-5.
Kohli P, Greenland P. Role of the metabolic syndrome in risk assessment for coronary heart disease. JAMA 2006;295:819-21.
Cortez-Dias N, Martins S, Fiuza M. Metabolic syndrome: An evolving concept. Rev Port Cardiol 2007;26:1409-21.
Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, et al. Elevated intakes of supplemental chromiumim prove glucose and insülin variables in individuals with Type 2 diabetes. Diabetes 1997;46:1786-91.
Preuss HG, Montamarry S, Echard B, Scheckenbach R, Bagchi D. Long-term effects of chromium, grape seed extract, and zinc on various metabolic parameters of rats. Mol Cell Biochem 2001;223:95-2.
Stearns DM. Is chromium a traceessential metal? Biofactors 2000;11:149-62.
Doddigarla Z, Ahmad J, Parwez I. Effect of chromium picolinate and melatonin either in single or in a combination in high carbohydrate diet-fed male wistar rats. Biofactors 2016;42:106-14.
Refaie FM, Esmat AY, Mohamed AF, Nour WH. Effect of chromium supplementation on the diabetes induced-oxidative stress in liver and brain of adult rats. Biometals 2009;22:1075.
Sundaram B, Singhal K, Sandhir R. Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes. Biofactors 2012;38:59-8.
Chen G, Liu P, Pattar GR, Tackett L, Bhonagiri P, Strawbridge AB, et al. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol 2006;20:857-70.
Sundaram B, Singhal K, Sandhir R. Anti-atherogenic effect of chromium picolinate in streptozotocin-induced experimental diabetes. J Diabetes 2013;5:43.
Nagarajrao R, Alharbi SA. Relationshıp between oxidant and antioxidant enzymes status in type 2 diabetic patients with nephropathy in saudi population. Asian J Pharm Clin Res 2018;11:363-8.
Sundaram B, Aggarwal A, Sandhir R. Chromium picolinate attenuates hyperglycemia induced oxidative stress in streptozotocin-induced diabetic rats. J Trace Elem Med Bio 2013;27:117-1.
Kuyvenhoven JP, Meinders AE. Oxidative stress and diabetes mellitus: Pathogenesis of long-term complications. Eur J Intern Med 1999;10:9-19.
Lai MH. Antioxidant effects and insulin resistance improvement of chromium combined with Vitamin C and E supplementation for Type 2 diabetes mellitus. J Clin Biochem Nutr 2008;43:191-8.
Jain SK, Patel P, Rogier K, Jain SK. Trivalent Chromium inhibits protein glycosylation and lipid peroxidation in high glucose-treated erythrocytes. Antioxid Redox Signal 2006;8:238-1.
Jain SK, Rains JL, Croad JL. Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 2007;43:1124-31.
Al-Rasheed NM, Attia, HA, Mohamed, RA, Al-Rasheed NM, Al- Amin MA. Preventive effects of selenium yeast, chromium picolinate, zinc sulfate and their combination on oxidative stress, inflammation, impaired angiogenesis and atherogenesis in myocardial infarction in rats. J Pharm Pharm Sci 2013;16:848-67.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
